FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:832-838 March 18, 1999 Number 11 Next

	Full Text PDF Editorial by Jacobsen, D. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Ethylene glycol poisoning causes metabolic acidosis and renal failure and may cause death. The standard treatment is inhibition of alcohol dehydrogenase with ethanol, given in intoxicating doses, and adjunctive hemodialysis. We studied the efficacy of fomepizole, a new inhibitor of alcohol dehydrogenase, in the treatment of ethylene glycol poisoning.

Methods We administered intravenous fomepizole to 19 patients with ethylene glycol poisoning (plasma ethylene glycol concentration, 20 mg per deciliter [3.2 mmol per liter]). Patients who met specific criteria also underwent hemodialysis. Treatment was continued until plasma ethylene glycol concentrations were less than 20 mg per deciliter. Acid–base status, renal function, the kinetics of fomepizole, and ethylene glycol metabolism were assessed at predetermined intervals.

Results Fifteen of the patients initially had acidosis (mean serum bicarbonate concentration, 12.9 mmol per liter). Acid–base status tended to normalize within hours after the initiation of treatment with fomepizole. One patient with extreme acidosis died. In nine patients, renal function decreased during therapy; at enrollment, all nine had high serum creatinine concentrations and markedly elevated plasma glycolate concentrations (97.7 mg per deciliter [12.9 mmol per liter]). None of the 10 patients with normal serum creatinine concentrations at enrollment had renal injury during treatment; all 10 had plasma glycolate concentrations at or below 76.8 mg per deciliter (10.1 mmol per liter). Renal injury was independent of the initial plasma ethylene glycol concentration. The plasma concentration of glycolate and the urinary excretion of oxalate, the major metabolites of ethylene glycol, uniformly fell after the initiation of fomepizole therapy. Few adverse effects were attributable to fomepizole.

Conclusions In patients with ethylene glycol poisoning, fomepizole administered early in the course of intoxication prevents renal injury by inhibiting the formation of toxic metabolites.

Source Information

From Toxicology Associates (J.B., S.P., M.W., K.K.), Sections of Clinical Pharmacology and Toxicology (J.B., S.P.), Emergency Medicine (J.B., K.K.), and Pediatric Pharmacology (J.B., K.K.), University of Colorado Health Sciences Center, Denver; the Department of Pharmacology, Louisiana State University Medical Center, Shreveport (K.M.); and the Department of Emergency Medicine and the Central Pennsylvania Poison Center, Milton S. Hershey Pennsylvania State Geisinger Health System, Hershey (K.K.B., J.W.D.).

Address reprint requests to Dr. Brent at Toxicology Associates, 2555 S. Downing St., Suite 260, Denver, CO 80210.

Full Text of this Article

This article has been cited by other articles:

• Schep, L. J, Slaughter, R. J, Vale, J A., Beasley, D M. G (2009). A seaman with blindness and confusion. BMJ 339: b3929-b3929 [Full Text]  
• Brent, J. (2009). Fomepizole for Ethylene Glycol and Methanol Poisoning. NEJM 360: 2216-2223 [Full Text]  
• Bestic, M., Blackford, M., Reed, M. (2009). Fomepizole: A Critical Assessment of Current Dosing Recommendations. J Clin Pharmacol 49: 130-137 [Abstract] [Full Text]  
• Schorn, R., Kalicki, R., Remschmidt, C., Schley, G., Hofliger, N., Aregger, F. (2008). Sweet and sour--a patient with life-threatening metabolic acidosis and acute renal failure. NDT Plus 1: 433-436 [Full Text]  
• Alzouebi, M, Sarrigiannis, P G, Hadjivassiliou, M (2008). Acute polyradiculoneuropathy with renal failure: mind the anion gap. J. Neurol. Neurosurg. Psychiatry 79: 842-844 [Abstract] [Full Text]  
• Kraut, J. A., Kurtz, I. (2008). Toxic Alcohol Ingestions: Clinical Features, Diagnosis, and Management. CJASN 3: 208-225 [Abstract] [Full Text]  
• Krenova, M, Pelclova, D (2007). Does unintentional ingestion of ethylene glycol represent a serious risk?. Hum Exp Toxicol 26: 59-67 [Abstract]  
• Betten, D. P., Vohra, R. B., Cook, M. D., Matteucci, M. J., Clark, R. F. (2006). Antidote Use in the Critically Ill Poisoned Patient. J Intensive Care Med 21: 255-277 [Abstract]  
• Takayesu, J. K., Bazari, H., Linshaw, M. (2006). Case 7-2006 -- A 47-Year-Old Man with Altered Mental Status and Acute Renal Failure. NEJM 354: 1065-1072 [Full Text]  
• Corley, R. A., McMartin, K. E. (2005). Incorporation of Therapeutic Interventions in Physiologically Based Pharmacokinetic Modeling of Human Clinical Case Reports of Accidental or Intentional Overdosing with Ethylene Glycol. Toxicol Sci 85: 491-501 [Abstract] [Full Text]  
• McMartin, K. E., Wallace, K. B. (2005). Calcium Oxalate Monohydrate, a Metabolite of Ethylene Glycol, Is Toxic for Rat Renal Mitochondrial Function. Toxicol Sci 84: 195-200 [Abstract] [Full Text]  
• Cruzan, G., Corley, R. A., Hard, G. C., Mertens, J. J. W. M., McMartin, K. E., Snellings, W. M., Gingell, R., Deyo, J. A. (2004). Subchronic Toxicity of Ethylene Glycol in Wistar and F-344 Rats Related to Metabolism and Clearance of Metabolites. Toxicol Sci 81: 502-511 [Abstract] [Full Text]  
• Luce, J. M. (2003). Update in Critical Care. ANN INTERN MED 139: 748-752 [Full Text]  
• Blondell, R. D., Dodds, H. N., Sexton, L. K. (2003). Ethanol in Hospital Formularies--Reply. JAMA 289: 2361-2361 [Full Text]  
• Mokhlesi, B., Leikin, J. B., Murray, P., Corbridge, T. C. (2003). Adult Toxicology in Critical Care: Part II: Specific Poisonings. Chest 123: 897-922 [Full Text]  
• Wallman, P., Hogg, K. (2002). Management of acute ethylene glycol poisoning. Emerg. Med. J. 19: 431-432 [Abstract] [Full Text]  
• Chu, J., Wang, R. Y., Hill, N. S. (2002). Update in Clinical Toxicology. Am. J. Respir. Crit. Care Med. 166: 9-15 [Full Text]  
• Jones, A L, Dargan, P I (2002). Advances, challenges, and controversies in poisoning.. Emerg. Med. J. 19: 190-192 [Full Text]  
• Brown, M. J., Shannon, M. W., Woolf, A., Boyer, E. W. (2001). Childhood Methanol Ingestion Treated With Fomepizole and Hemodialysis. Pediatrics 108: e77-77 [Abstract] [Full Text]  
• Sarkola, T., Adlercreutz, H., Heinonen, S., von der Pahlen, B., Eriksson, C. J. P. (2001). The Role of the Liver in the Acute Effect of Alcohol on Androgens in Women. J. Clin. Endocrinol. Metab. 86: 1981-1985 [Abstract] [Full Text]  
• Brent, J., McMartin, K., Phillips, S., Aaron, C., Kulig, K., The Methylpyrazole for Toxic Alcohols Study Group, (2001). Fomepizole for the Treatment of Methanol Poisoning. NEJM 344: 424-429 [Abstract] [Full Text]  
• Casavant, M. J. (2001). Fomepizole in the Treatment of Poisoning. Pediatrics 107: 170-171 [Full Text]  
• Boyer, E. W., Mejia, M., Woolf, A., Shannon, M. (2001). Severe Ethylene Glycol Ingestion Treated Without Hemodialysis. Pediatrics 107: 172-173 [Abstract] [Full Text]  
• Baum, C. R., Langman, C. B., Oker, E. E., Goldstein, C. A., Aviles, S. R., Makar, J. K. (2000). Fomepizole Treatment of Ethylene Glycol Poisoning in an Infant. Pediatrics 106: 1489-1491 [Abstract] [Full Text]  
• Liebelt, E. L., DeAngelis, C. D. (1999). Evolving Trends and Treatment Advances in Pediatric Poisoning. JAMA 282: 1113-1115 [Full Text]  
• (1999). Fomepizole Treats Ethylene Glycol Poisoning. JWatch Emergency Med. 1999: 1-1 [Full Text]  
• Jacobsen, D. (1999). New Treatment for Ethylene Glycol Poisoning. NEJM 340: 879-881 [Full Text]